VivoSim Labs Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	-	2.9	15.3	28.68	37.36
Short-Term Investments	-	-	-	0.71	-	-
Cash & Short-Term Investments	-	-	2.9	16.01	28.68	37.36
Cash Growth	-	-	-81.88%	-44.18%	-23.25%	36.58%
Accounts Receivable	-	-	0.03	0.15	-	-
Other Receivables	-	1.01	-	-	-	-
Total Trade Receivables	-	1.01	0.03	0.15	-	-
Inventory	-	-	0.3	-	-	-
Other Current Assets	-	-	0.71	0.89	0.86	1.03
Total Current Assets	-	1.01	3.94	17.05	29.53	38.4
Net Property, Plant & Equipment	-	-	1.97	2.61	2.82	0.38
Other Long-Term Assets	-	1	0.45	0.66	0.95	1.14
Total Assets	-	2.01	6.35	20.31	33.3	39.92
Accounts Payable	-	-	0.63	0.33	0.42	0.28
Accrued Expenses	-	-	0.73	2.85	0.49	0.44
Short-Term Debt	0.24	0.13	-	-	-	-
Current Portion of Leases	-	-	0.51	0.49	0.48	-
Other Current Liabilities	0.22	0.22	-	-	-	-
Total Current Liabilities	0.45	0.35	1.86	3.67	1.38	0.72
Long-Term Leases	-	-	0.89	1.31	1.7	-
Total Long-Term Liabilities	-	-	0.89	1.31	1.7	-
Total Liabilities	0.45	0.35	2.75	4.98	3.09	0.72
Common Stock	-	-	0	0.01	0.01	0.01
Treasury Stock	-	-0	-0	-0	-0	-0
Additional Paid-in Capital	-	-	343.27	340.32	337.94	335.48
Accumulated Other Comprehensive Income	-	-	-	0	-	-
Retained Earnings	-	-	-339.67	-325	-307.74	-296.29
Shareholders' Equity	-	-0	3.6	15.33	30.21	39.2
Total Liabilities & Equity	0.45	0.35	6.35	20.31	33.3	39.92
Total Debt	0.24	0.13	1.39	1.81	2.18	0
Net Cash (Debt)	-0.24	-0.13	1.51	14.2	26.49	37.36
Net Cash Growth	-	-	-89.39%	-46.39%	-29.10%	36.58%
Net Cash Per Share	-0.09	-0.09	1.98	19.56	36.53	64.96
Book Value	-	-0	3.6	15.33	30.21	39.2
Book Value Per Share	-	-0.00	4.73	21.11	41.65	68.15
Tangible Book Value	-	-0	3.6	15.33	30.21	39.2
Tangible Book Value Per Share	-	-0.00	4.73	21.11	41.65	68.15

SEC Filings: 10-K · 10-Q